Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susmita G Ramanand

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Molecular Cell|August 5, 2022
Stress and the CITISusmita G Ramanand, Ram S Mani
Advances in Experimental Medicine and Biology|January 5, 2020
Genetic, Environmental, and Nuclear Factors Governing Genomic RearrangementsSusmita G Ramanand, Ram S Mani
Translational Oncology|June 9, 2021
Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer TherapyRanjit K Mehta, Sushmita Shukla, Susmita G Ramanand, et al.
Cancer Research|March 11, 2010
Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancerAarif Ahsan, Susan M Hiniker, Susmita G Ramanand, et al.
The Journal of Biological Chemistry|July 31, 2013
Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerizationAarif Ahsan, Dipankar Ray, Susmita G Ramanand, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenograftsAarif Ahsan, Susmita G Ramanand, Ingrid L Bergin, et al.
The Journal of Clinical Investigation|June 15, 2022
FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activitySubhransu S Sahoo, Susmita G Ramanand, Yunpeng Gao, et al.
Cancer Discovery|September 15, 2022
Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic ArchitectureJiapei Yuan, Kathleen E Houlahan, Susmita G Ramanand, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumorsAarif Ahsan, Susmita G Ramanand, Christopher Whitehead, et al.
Head & Neck|August 22, 2012
Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinomaChristina I Tsien, Mukesh K Nyati, Aarif Ahsan, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Molecular Cell|August 5, 2022
Stress and the CITISusmita G Ramanand, Ram S Mani
Advances in Experimental Medicine and Biology|January 5, 2020
Genetic, Environmental, and Nuclear Factors Governing Genomic RearrangementsSusmita G Ramanand, Ram S Mani
Translational Oncology|June 9, 2021
Disruptin, a cell-penetrating peptide degrader of EGFR: Cell-Penetrating Peptide in Cancer TherapyRanjit K Mehta, Sushmita Shukla, Susmita G Ramanand, et al.
Cancer Research|March 11, 2010
Role of epidermal growth factor receptor degradation in cisplatin-induced cytotoxicity in head and neck cancerAarif Ahsan, Susan M Hiniker, Susmita G Ramanand, et al.
The Journal of Biological Chemistry|July 31, 2013
Destabilization of the epidermal growth factor receptor (EGFR) by a peptide that inhibits EGFR binding to heat shock protein 90 and receptor dimerizationAarif Ahsan, Dipankar Ray, Susmita G Ramanand, et al.
Neoplasia (New York, N.Y.)|April 9, 2014
Efficacy of an EGFR-specific peptide against EGFR-dependent cancer cell lines and tumor xenograftsAarif Ahsan, Susmita G Ramanand, Ingrid L Bergin, et al.
The Journal of Clinical Investigation|June 15, 2022
FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activitySubhransu S Sahoo, Susmita G Ramanand, Yunpeng Gao, et al.
Cancer Discovery|September 15, 2022
Prostate Cancer Transcriptomic Regulation by the Interplay of Germline Risk Alleles, Somatic Mutations, and 3D Genomic ArchitectureJiapei Yuan, Kathleen E Houlahan, Susmita G Ramanand, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumorsAarif Ahsan, Susmita G Ramanand, Christopher Whitehead, et al.
Head & Neck|August 22, 2012
Effect of erlotinib on epidermal growth factor receptor and downstream signaling in oral cavity squamous cell carcinomaChristina I Tsien, Mukesh K Nyati, Aarif Ahsan, et al.
Pageof 2